CRISPR/Cas
EPO upholds Berkeley divisional CRISPR patent
The EPO Opposition Division has upheld a CRISPR/Cas9 patent belonging to the University of California (Berkeley), University of Vienna, and Emmanuelle Charpentier, following a 15-hour hearing. However
...
1 March 2022 by Amy Sandys